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Abstract: Carbamyl phosphate (CP) is well-known as an essential intermediate of pyrimidine and
arginine/urea biosynthesis. Chemically, CP can be easily synthesized from dihydrogen phosphate and
cyanate. Enzymatically, CP can be synthesized using three different classes of enzymes: (1) ATP-grasp
fold protein based carbamyl phosphate synthetase (CPS); (2) Amino-acid kinase fold carbamate kinase
(CK)-like CPS (anabolic CK or aCK); and (3) Catabolic transcarbamylase. The first class of CPS can be
further divided into three different types of CPS as CPS I, CPS II, and CPS III depending on the usage
of ammonium or glutamine as its nitrogen source, and whether N-acetyl-glutamate is its essential
co-factor. CP can donate its carbamyl group to the amino nitrogen of many important molecules
including the most well-known ornithine and aspartate in the arginine/urea and pyrimidine
biosynthetic pathways. CP can also donate its carbamyl group to the hydroxyl oxygen of a variety of
molecules, particularly in many antibiotic biosynthetic pathways. Transfer of the carbamyl group to
the nitrogen group is catalyzed by the anabolic transcarbamylase using a direct attack mechanism,
while transfer of the carbamyl group to the oxygen group is catalyzed by a different class of enzymes,
CmcH/NodU CTase, using a different mechanism involving a three-step reaction, decomposition
of CP to carbamate and phosphate, transfer of the carbamyl group from carbamate to ATP to form
carbamyladenylate and pyrophosphate, and transfer of the carbamyl group from carbamyladenylate
to the oxygen group of the substrate. CP is also involved in transferring its phosphate group to ADP
to generate ATP in the fermentation of many microorganisms. The reaction is catalyzed by carbamate
kinase, which may be termed as catabolic CK (cCK) in order to distinguish it from CP generating CK.
CP is a thermally labile molecule, easily decomposed into phosphate and cyanate, or phosphate and
carbamate depending on the pH of the solution, or the presence of enzyme. Biological systems have
developed several mechanisms including channeling between enzymes, increased affinity of CP to
enzymes, and keeping CP in a specific conformation to protect CP from decomposition. CP is highly
important for our health as both a lack of, or decreased, CP production and CP accumulation results
in many disease conditions.
Keywords: carbamyl phosphate; urea cycle; arginine biosynthesis; pyrimidine biosynthesis;
transcarbamylase; carbamate kinase

1. Introduction
Carbamyl phosphate (CP), discovered and synthesized by Jones and Lipmann in 1955 [1], is an
interesting compound combining ammonia, carbonate, and phosphate in a single molecule. It is
believed that CP may have originated in the prebiotic world providing a source of a carbamyl group
for the biosynthesis of many important organic molecules such as pyrimidine and arginine, and the
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source of a phosphate group to ADP to make ATP, that are crucial for all forms of life [2,3]. It was
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CP as one of eight key small molecules to power cell metabolism [15] provides the carbamyl group
for many biosynthetic pathways. The most well-known pathways are the urea/arginine pathway
that produces urea and arginine and the pyrimidine pathway that provides essential nucleotides for
DNA synthesis [1,4,16]. However, many antibiotic synthesis pathways also involve the carbamyl
group transfer from CP to either amino groups or a hydroxyl group [17–23]. Furthermore, CP even
participates in the [NiFe] hydrogenase maturation by providing the CN group to the [NiFe] cluster.
In this process, the hydrogenase pleiotropically acting protein A (HypA) catalyzes a carbamyl transfer
reaction from carbamate, which is generated from CP, to the C-terminal cysteine residue of HypE via a
carbamyladenylate intermediate [24]. HypE catalyzes an ATP-dependent dehydration to produce a
thiocynate group, whose cyano group then eventually becomes the ligand of [NiFe](CN)2 CO’s active
site center for [NiFe] hydrogenase.
This review article focuses on how CP is generated biochemically and enzymatically and how CP
is involved in the biosynthesis of many important biological molecules including arginine, pyrimidine,
and ATP. CP was last reviewed by Jones in 1963 and many new insights have been obtained about its
generation and usage since then. It is an opportune time to summarize many facets of this important
small molecule, which is a well-known essential intermediate of pyrimidine and arginine/urea
biosynthesis and is highly correlated with human health.
2. Production of CP Chemically
Chemically, CP is easily produced by mixing dihydrogen phosphate with cyanate in a solution [1].
In brief, equal moles of dihydrogen phosphate and cyanate are mixed and warmed to 30◦ for 30 min.
Then, the solution is cooled on ice, to which an ice-cold solution of the mixture of lithium hydroxide
and perchloric acid is added to adjust to a final pH of 8.3. The precipitate, which consists of potassium
perchlorate and lithium phosphate, is removed by filtration. About 90% to 95% pure dilithium CP can
be obtained by adding ethanol slowly to the filtrate.
3. Production of CP in Biological Systems
3.1. Production of CP Using CPS
In biological systems, several enzymes are able to catalyze the formation of CP.
Carbamyl phosphate synthetase (CPS) is the most common one; it occurs in nearly all organisms and is a
multi-domain protein with about 1500 amino acid residues comprising one or two or more polypeptide
chains. Three different types of CPS termed CPS I, CPS II, and CPS III are recognized depending on
the nitrogen sources and allosteric activator [25]. CPS I uses only ammonia as the nitrogen-donating
substrate and requires N-acetyl-glutamate (NAG) as its essential allosteric activator. This enzyme is
located in mitochondria and functions as the first step to remove ammonia in the liver via the urea
cycle and to make arginine by the combined actions of intestine, which contains CPS1, and the kidney,
that makes arginine from citrulline [26,27]. CPS II uses glutamine as its nitrogen-donating substrate
and does not require NAG for activity. In humans, CPS II is located in the cytosol as a pyrimidine
biosynthesis enzyme and forms a multifunctional complex (termed CAD) with the next two enzymes
of the pyrimidine biosynthetic pathway, aspartate transcarbamylase (ATCase) and dihydroorotase
(DHO). CPS II is also present in fungi and bacteria. Fungi have two different forms of CPS II, one is
pyrimidine-specific, and one is arginine-specific, but bacteria usually only have one CPS II for both
pathways. The fungal pyrimidine-specific CPS II is fused to ATCase and active or inactive DHO
similar to human multifunctional complex CAD. The fungal arginine-specific and bacterial CPS II
is either a heterodimer consisting of glutaminase and synthase subunits, or a single peptide with
both subunits fused. CPS III, which is found in invertebrates and fish, is composed of one single
peptide and uses glutamine as a nitrogen-donating source and requires NAG for optimal activity [25],
suggesting that CPS III is an evolutionary intermediate in the transition from glutamine-dependent
CPS II to ammonia-dependent CPS I.

Biology 2018, 7, 34

4 of 23

E. coli CPS belongs to the CPS II family and is one of the best studied CPSs, composed of a 40-kDa
glutaminase (CarA, GLN) subunit and a 120 kDa synthase (CarB, SYN) subunit [28]. The CarA subunit
catalyzes the hydrolysis of glutamine to generate ammonia, which transfers to the CarB subunit.
The CarB subunit consists of two homologous domains, CPS.A and CPS.B. The amino half domain
catalyzes the formation of carbamate from ATP, bicarbonate, and ammonia, while the carboxyl half
domain catalyzes the formation of CP from the second ATP and carbamate [29–31]. CPS.A and CPS.B
are divided further into two subdomains, respectively, as bicarbonate phosphorylation domain (A1),
integrating domain (A2) and carbamate phosphorylation domain (B1), allosteric domain (B2) [29,32].
The structure of E. coli CPS demonstrates that A1 and B1 have nearly identical folds while A2 and
B2 have distinctly different tertiary structures [7]. The active sites are located at the A1 and B1
subdomains and the regulator-binding site is at the B2 subdomain. The structures of A1 and B1 belong
to a superfamily termed “ATP-grasp” fold family that has more than 31 member proteins [5,33–35]
(Figure 2). The ATP-grasp fold consists of two α + β domains that “grasp” ATP between them and
members of the family typically have three subdomains termed A, B and C domains. All members of
the ATP-grasp family catalyze an ATP-dependent ligation of a carboxyl group carbon of a substrate
to an amino or imino group nitrogen of a second substrate. The substrates are quite diverse; the first
substrate can take the form of a protein, a short peptide, an amino acid, or even a small chemical such
as an organic or inorganic acid (carbonic, malic, succinic, and citric) whereas the second substrate
can be an amino acid (Glu, Gly, Val, D-Ala, and Tyr), a thiol group (CoA), a biotinylated protein,
or even a small molecule such as ammonia [34]. The catalytic mechanism of most members of the
ATP-grasp family can be broken into two partial reactions, the reaction of the first substrate with ATP
to form acylphosphate and the reaction of acylphosphate with the second substrate to form product.
In these cases, members of the ATP-grasp family act as ligases. However, some members of the ATP
grasp family do not have the second substrate and the acylphosphate is its product. In this case,
these members act as kinases [35]. Remarkably, CPS combines ligase and kinase reactions into one
enzyme with the A1 domain for the ligase reaction using bicarbonate as the first substrate and ammonia
as the second substrate to form carbamate intermediate and the B1 domain for the kinase reaction
using carbamate as the first substrate only to form the final product CP. Ammonia and carbamate
are labile chemicals. Thus, a 96 Å long intermolecular channel is present in E. coli CPS to connect the
active site of GLN domain and the active sites of the CPS.A and CPS.B domains to allow ammonia to
transfer from GLN to the CPS.A domain and carbamate from the CPS.A to the CPS.B domain without
equilibrating with the bulky solvent [7]. Similar intermolecular channels for ammonia and carbamate
can be found in many enzymes [24,36].
Because of the essential role of CPS I in the urea cycle, human CPS I is also one of enzymes
being intensely investigated [37–39]. Recently, the structures of human CPS I with and without the
presence of NAG were determined [6,40], demonstrating that binding of NAG in the allosteric domain
B2 (termed L4 in human CPS I structure) causes dramatic conformational changes of CPS I to re-shape
both phosphorylation active sites in domains A1 and B1 (termed L1 and L3, respectively, in human
CPS I structure) and the intramolecular tunnel for carbamate migration between them. The structures
clearly show that CPS I can be in two distinctly different conformations as the inactive or active state
upon the absence and presence of NAG and demonstrate the detailed molecular mechanism for NAG’s
role as a switch to turn on/off the CPS I activity and eventually the ureagenesis.
The full length CPS can be composed of a single peptide chain such as CPS I and CPS III,
two peptide chains such as CPS II, or even more peptide chains. In Aquifex aeolicus, CPS is encoded
with the split genes for separate CPS.A, CPS.B, and GLN [41]. The isolated CPS.A and CPS.B subunits
can catalyze both ATP-dependent partial reactions: the activation of bicarbonate to form carbamate
and the phosphorylation of carbamate to form CP. Mixtures of equimolar amounts of CPS.A, CPS.B,
and GLN will form a single complex with a molecular weight of 171 KDa able to catalyze the full
glutamine dependent CP synthesis reaction. Even though the separated CPS.A and CPS.B are required
by most CPS for the full three-step production of CP, it is not essential. Recently, a smallest CPS with
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a molecular weight of only 41 KDa was identified in human gut archaeon Methanobrevibacter smithii.
The functional unit of this small CPS is a dimer corresponding to the two synthetase domains of
the full-length CPS that catalyze the full three-step reaction [42]. It is now clear that the full length
CPSs have arisen by gene duplication, translocation, and fusion of an ancestral ATP grasp fold
kinase followed by the independent mutation of the domains for more specialized functions and the
acquisition of a glutaminase able to use glutamine as a nitrogen-donating substrate [43–46].

Figure 2. Ribbon diagram of the structure of A1 (bicarbonate phosphorylation) and B1 (carbamate
phosphorylation) domains of E. coli CPS (A) (PDB ID: 1jdb) and human CPS I (B) (PDB ID: 5dou).
Both bicarbonate phosphorylation domain and carbamate phosphorylation domain in E. coli CPS
and human CPS I have very similar folds with A1 and B1 having the traditional ATP-grasp protein
fold with the N-terminal domain (domain A) in blue to light blue, the central domain (domain B) in
green, and the C-terminal domain (domain C) in yellow to brown. The K-loops (residues 654–662
and 1197–1205 in human CPS I and residues 237–245 and 782–790 in E. coli CPS) are corresponding to
the ATP binding loops in ATP-grasp proteins. In comparison to the traditional ATP-grasp proteins,
both the carbonate and carbamate phosphorylation domains have an extra domain (shown in red),
which hosts a T-loop (residues 777–793 and 1314–1330 in human CPS I, residue 362–378 and 895–911 in
E. coli CPS). The bound ADP shown in stick model is located at the cleft between domains B and C,
and covered by the T-loop of the extra domain.
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3.2. Production of CP Using Carbamate Kinase
The formation of CP from ammonia (or glutamine), bicarbonate, and ATP in most organisms uses
the above irreversible three-step reaction. However, CP can also be formed directly from carbamate and
ATP in a reaction catalyzed by an entirely different enzyme, carbamate kinase (CK). This enzyme can
substitute in vivo for CPS [47]. Thus, in some archaea such as P. abyssi and Thermococcus kodakarensis,
in which no canonical CPS genes are identified, CK acts as the source of CP for anabolic purposes
and therefore could be called CK-like CPS [9–12,48–50]. Since the reaction is reversible, the CP
synthesis requires the presence of high concentrations of ammonia, which reacts with bicarbonate
to form carbamate non-enzymatically, the substrate for CK-like CPS. Since CK-like CPS plays an
anabolic role in vivo to produce CP needed for the synthesis of pyrimidine and arginine, we will term
this CP-like CPS as anabolic CK, in order to distinguish it from closely related carbamate kinases
(termed catabolic CK), which use CP generated from catabolic transcarbamylases to make ATP [10].
In many hyperthermophillic archaea such as P. abyssi and T. kodakarensis, the sequence of the classical
CPS in the genome could not be identified, implying that this anabolic CK plays a functional role
in vivo in making CP, rather than in using CP. Furthermore, kinetics evidence demonstrated that
P. furiosus CK with both OTCase and ATCase is involved in the channeling of thermolabile CP to
conform its anabolic role [51].
The high sequence identity of CKs of P. furiosus and P. abyssi (276 of the 314 residues are identical,
with 31 of the 38 substitutions being conservative replacements) indicates that the P. furiosus protein [10]
should be a good model for the structure of P. abyssi anabolic CK. The structure of this CK is
similar to the structures of catabolic CKs (Figure 1), which uses CP to make ATP in the catabolic
pathway [49,52–54], even though they should play different biological roles in vivo. The general fold
of anabolic CK belongs to the family of amino acid kinases, whose members include N-acetyl-glutamate
kinase [55], uridylate kinase [56], glutamate-5 kinase [57], the fosfomycin-inactivating kinase
FomA [58], and aspartokinase [59]. Although the anabolic CK catalyzes the same reaction as the
third step of reaction of the typical CPS (Section 3.1), neither the overall shape, the general fold, nor the
disposition of the active sites has structural similarity between these two enzymes, contradicting earlier
thoughts that both enzymes might have evolved from a common ancestral gene [43,60,61].
3.3. Production of CP Using Catabolic Transcarbamylases
CP can also be produced by a third class of entirely different enzymes, the catabolic
transcarbamylases, in a fermentation process in microorganisms that includes some pathogens
of medical interest such as Mycoplasma penetrans [53], Giardia lamblia [62], and T. vaginalis [16].
Catabolic transcarbamylase promotes phosphorolysis of ureido-containing compounds such as
citrulline and carbamylputrescine to produce CP. Since this reaction is thermodynamically unfavorable,
the reaction needs to couple with a downstream enzyme, carbamate kinase (catabolic CK). Gene context
analysis indicates that most of the catabolic transcarbamylase genes are located in the vicinity
of the carbamate kinase gene [63–70] and further confirmed the characteristic co-transcription of
these two genes, which might be used to distinguish the catabolic transcarbamylase from anabolic
transcarbamylase [16].
The best-known catabolic transcarbamylase is the catabolic ornithine transcarbamylase (OTCase)
in the arginine deiminase pathway. The function and structures for catabolic OTCase in Pseudomonas
aeruginosa have been studied in detail [4,13,14,71–73]. Even though anabolic and catabolic OTCase
have high sequence similarity and catalyze the same reaction in opposite directions, in most organisms,
distinct enzymes catalyze the arginine biosynthesis pathway and the catabolic arginine-deiminase
pathway, respectively. Kinetically, catabolic OTCase shows highly cooperative CP binding, and AMP,
CMP, and inorganic phosphate are activators of the enzyme [71]. The structures of catabolic OTCase
from P. aeruginosa [72], M. penetrans [53], and Lactobacillus hilgardii [73] show that most catabolic
OTCases have higher oligomeric structures such as a dodecamer or hexamer, in contrast to the trimeric

Biology 2018, 7, 34

7 of 23

structure of anabolic OTCase [16]. However, catabolic OTCase from G. lamblia is an exception since it
functions as a trimer [74].
The putrescine transcarbamylase (PTCase) has also been known for many years and plays a
catabolic role in the agmatine deiminase pathway using agmatine, the decarboxylated analogue
of arginine, as a fermentative source of ATP [70,75,76]. Interestingly, PTCase uses a trimer as its
functional molecular machinery in contrast to the catabolic OTCase, which usually assembles into a
higher oligomer [16,64,77]. PTCase is unique as it uses the extra C-terminal helix to stabilize the trimer
and prevent higher order oligomerization [64,77].
Besides the above two known catabolic transcarbamylases, CP can be generated using other
catabolic transcarbamylases. It was believed that an oxamate transcarbamylase is involved in
using oxalurate, a degradation product of purine, as a fermentative source to generate CP for
producing ATP [78–81]. An ygeW gene encoded transcarbamylase in E. coli was proposed to catalyze
this reaction [80]. However, recent studies with the recombinant protein could not confirm the
oxamate transcarbamylase activity [63]. Even though the exact biological function for the ygeW
encoded transcarbamylase still remain elusive, its biological function is most likely to be a catabolic
transcarbamylase to produce CP for generating ATP. In a recent publication, a new alternative route
for purine catabolism has been described, and a novel ureidoglycine transcarbamylase that uses
allantoate to generate CP was identified and confirmed experimentally [68], demonstrating the need
for continued investigation into the kinds of ureido-containing compounds that microorganisms can
use as the energy source to make CP for ATP.
4. CP as Carbamyl Group Donor
CP has been known for more than 60 years to be a source of the carbamyl group that is incorporated
into organic molecules in many forms of life [1,3]. The carbamyl group can be added onto either
a nitrogen- or an oxygen-containing functional group, or even groups containing sulfur atoms.
Very different enzymes catalyze the reactions in these carbamylation reactions. Since carbamylation
of the nitrogen group is involved in several important pathways such as the arginine biosynthetic
pathway, urea cycle, and pyrimidine pathway, this group of enzymes is best understood [16].
4.1. Amino Nitrogen as a Carbamyl Group Acceptor
The amino nitrogen containing acceptor molecules include aspartate, ornithine, and various
ornithine derivatives such as N-acetyl-, N-succinyl-L-ornithine or ornithine-containing peptides,
and L-2,3-diamminopropionate and L-2,4-diaminobutyrate (Figure 3). The enzymes catalyzing this
group of reactions are termed N-transcarbamylases (or transcarbamylases since they are better known
than O-transcarbamylases, see Section 4.2). Phylogenetic analysis indicates that all members of this
group of transcarbamylases can be traced back to a common ancestor gene [68,82,83]. The basic
catalytic unit is a trimer with a similar protein topology to that of a subunit consisting of the N-terminal
CP domain and the C-terminal acceptor-binding domain. Both domains have a αβα structure with a
parallel β-sheet in the center and α helices on both sides [84]. They use a common catalytic mechanism
with direct attack of the carbamyl carbon of CP by the amino nitrogen of the second substrate to form
reaction product [16] (Figure 4).
4.1.1. Aspartate as Acceptor
Carbamylation of the α-amino group of aspartate to form N-carbamyl-L-aspartate, catalyzed by
ATCase, is the first reaction step in the de novo pyrimidine biosynthetic pathway [85,86].
Phylogenetic analysis classifies ATCase into two families, ATC I and ATC II [68,83]. According to
the way ATCase associates with other proteins, ATCase can be divided into three classes in bacteria.
ATCase in class A forms a stable dodecamer complex with the active or inactive dihydroorotase
(fused or non-fused), the next enzyme in the pyrimidine biosynthetic pathway [87,88]. ATCase in class
B is also a dodecamer complex but with regulatory subunits (fused or unfused) [84,89]. ATCase in
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Class C contains the catalytic trimer only [90]. In animals and fungi, the ATCase is fused with both
CPS II and DHO (active or inactive) to form a CAD complex [44,91,92]. ATCase in plants belongs to
Class CBiology
with2018,
the7,catalytic
trimer
x FOR PEER
REVIEWonly, but is sensitive to allosteric effectors [93,94].
8 of 22
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Many crystal structures of ATCase with or without the associated proteins have been
determined [16]. ATCase structures from E. coli, which represented the ATCase in class B, were studied
in most detail as a model of allosteric enzymes [84,86]. The whole holoenzyme consists of two ATCase
trimers at polar positions and three regulatory dimers at equatorial positions forming a dodecamer
structure. Two significantly different conformations, T and R states, were identified. Either substrate
or nucleotide binding alters the conformation by shifting the equilibrium between T and R states.
The structure of ATCase complexed with DHO, which represents the ATCase in class A, was also
resolved from A. aeolicus [95]. The dodecamer is arranged in such a way that two ATCase trimers are
located at the two polar ends and three dihydroorotase dimers at the equator to form a hollow reactor
with an internal reaction chamber about 60 Å in diameter. A similar structural arrangement to that of
the core scaffold of CAD was recently proposed based on the human and fungus DHO and ATCase
structural studies [96].
4.1.2. Ornithine and Other Ornithine Derivatives as Acceptors
The anabolic ornithine transcarbamylase catalyzes the transfer of the carbamyl group from
CP to the δ-amino group of ornithine to form citrulline in the urea cycle and arginine biosynthetic
pathway. Several alternative arginine biosynthetic pathways were recently identified to demonstrate
that different ornithine derivatives such as N-acetyl-ornithine, N-succinyl-ornithine, and even ornithine
containing tripeptides could be the acceptor of the carbamyl group of CP [97–100]. In plants, canaline,
an analogue of ornithine, can also be used as the acceptor of the carbamyl group in the canavanine
biosynthetic pathway using a similar route to that for arginine synthesis [101,102].
Many crystal structures of anabolic transcarbamylases involved in the urea cycle and/or arginine
biosynthetic pathway were determined [16]. Their biological functional unit is a trimer in contrast to
the catabolic OTCase, whose molecular unit is usually in a higher oligomer. Interestingly, two different
folding structures, one with 31 trefoil knot N-acetylornithine and N-succinylornithine transcarbamylase
and one without with OTCase, were identified [99,100,103].
4.1.3. L-2,3-diaminopropionate and L-2,4-diaminobutyrate as Acceptor
In the biosynthesis of the antibiotics, viomycin, capreomycins, tuberactinomycines,
and zwittermicin A, one reaction step involves the transfer of carbamyl group from CP to
L -2,3-diaminopropionate to form β-ureidoalanine [19,20,104]. Similarly, a reaction to transfer the
carbamyl group from CP to L-2,4-diaminobutyrate was found to be involved in the biosynthesis of
padanamide A [17]. The enzymes that catalyze these reactions were termed L-2,3-diaminopropionate
and L-2,4-diaminobutyrate transcarbamylase (DPTCase and DBTCase), respectively. Even though
the structures of DPTCase and DBTCase have not been determined, bioinformatics analysis of
their sequences clearly demonstrated that they closely resemble anabolic OTCase with a similar
three-dimensional structural fold and a similar catalytic mechanism. Both DPTCase and DBTCase
have SXRTR and HPXQ common CP binding motifs similar to other transcarbamylases. However,
unlike OTCase that has conserved DXXXSMG and HCLP ornithine binding motifs, both DPTCase and
DBTCase show deviation from these conserved motifs and are replaced by TRWQSMG and HDLP in
DPTCase, and S/TRWQTTG and HDLP in DBTCase, respectively [16].
4.2. Hydroxyl Oxygen as a Carbamyl Group Acceptor
The transfer of the carbamyl group of CP to the hydroxyl group of substrates (O-carbamylation)
has been observed in the biosynthesis of a variety of secondary metabolites, including antibiotics such
as cephalomycin [105], novobiocin [106], concanamycin A [107], ansamitocin and its derivatives [21,
108], tobramycin [109], polyoxin [110], carbamyl-albicidin [23], and nebramycin [111], as well
as rhizobial nodulation (Nod) factors [112] and saxitoxin [113]. In general, the substrates for
O-transcarbamylases are much larger and more diverse than those of N-transcarbamylases (Figure 5).
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the relocation of the carbamyladenylate intermediate. The reaction mechanism of O-transcarbamylase
via the carbamyladenylate intermediate (Figure 4) differs from that of N-transcarbamylases, which use
direct transfer of the carbamyl group from CP to the substrates without involving any intermediate [16].
4.3. Sulfur Group as an Acceptor
In a key step of [NiFe]-hydrogenase complex biosynthesis, an enzyme, termed HypF, involves the
catalysis of the carbamylation of the C-terminal cysteine residue of HypE, another enzyme in the
pathway [115,116]. HypF consists of four domains: the acylphosphatase (ACP) domain, Zn finger-like
domain, YrdC-like domain, and Kae1-like domain [117] (Figure 6). In comparison to the sequences of
O-transcarbamylases, the consecutively fused YrdC-like domain and Kae1-like domain are arranged
in reversed order with the YrdC-like domain in the N-terminal end and the Kae1-like domain
in the C-terminal end. Furthermore, HypE employs two extra domains, ACP and Zn finger-like
domains, to promote the decomposition of CP to carbamate and phosphate. Three active sites,
which are involved in three reaction steps—decomposition of CP to carbamate, carbamyadenylation,
and carbamyltransferation, respectively—were identified in the HypF structure with the direct
distances between the first active site to the second active, and the second active site to the third active
site of ~33 Å and ~15 Å, respectively [24]. Since carbamate and carbamyladenylate are highly labile in
solution, similar to the mechanism used in E. coli CPS and human CPS I [6,7], an intramolecular channel
connects these three active sites to allow carbamate to transfer from the site of CP decomposition to
the carbamyladenylation site, and carbamyladenylate to the carbamyltranslation site (Figure 6).

Figure 6. Ribbon diagram of the S-transcarbamylase, HypF. It catalyzes the carbamyl transfer
reaction from CP to the C-terminal cysteine residue of HypE, another enzyme in the pathway.
HypF consists of four domains: the acylphosphatase (ACP) domain, Zn finger-like domain, YrdC-like
domain, and Kae1-like domain, which were colored as blue, light-blue, green and yellow to red,
respectively. HypF uses the same three-step reaction mechanism for carbamyl transfer reaction as
O-transcarbamylases. The bound PO4 , AMPCPP and AMPCP, shown in stick models, mark the
active sites 1, 2, and 3, respectively. The carbamate generated in the active site 1 will migrate
towards the active 2 where it reacts with ATP to form carbamyladenylate via an intramolecular
tunnel, then carbamyladenylate moves to the active site 3 to react with the substrate to form product.
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5. CP as Phosphate Group Donor for ATP Production
ATP production from CP and ADP is catalyzed by catabolic CK donating the phosphate
group of CP to ADP in the final step of the microbial fermentative catabolism of arginine
and agmatine [52,76,118,119], and purine [68,79,81]. These catabolic pathways can be found
in Bacteria [118], Archaea [120], and amitochondral Eukarya [121,122]. It is also believed that
the pathways are essential for some organisms to survive such as G. lamblia [123]. Given the
absence of fermentation pathways in higher eukaryotes including humans and the importance
of energy-generation in a number of pathogenic microorganisms including S. mutants, E. faecalis,
M. penetrans, G. lamblia, and T. vaginalis, these pathways become attractive drug development targets
for some parasitic and bacterial infections.
Several catabolic CK structures have been determined including CK from G. lamblia [62],
M. penetrans [53], and E. faecalis [54]. All these CK structures have a similar α3 β8 α4 sandwich fold with
an eight-stranded β-sheet at the center and additional α helices at both sides of the central β-sheet.
The CK functions as a homodimer with the central β-sheet continuing across the dimerization interface
to form a 16-stranded molecular β-sheet that spans the entire molecule (Figure 1). The structures of
catabolic CK are also essentially identical to that of anabolic CK [10,49], excepting some conformational
differences in the active site and positional differences of the protruding subdomain [54]. It seems
that whether CK plays an anabolic or catabolic role in vivo strongly depends on the presence of other
enzymes and the surrounding environment, in contrast to the situation between anabolic and catabolic
OTCase, in which significant differences in the oligomeric state and kinetics properties are found.
CK serves an anabolic role to make CP possibly only in thermophilic archaea that live in environments
able to produce carbamate non enzymatically [11].
6. Protection of CP
CP is a thermally unstable chemical with a half-life of ~5 min at 37 ◦ C and physiological pH [124].
The half-life of CP at high temperatures such as 95–100 ◦ C, the environment for thermophilic organisms
to grow, is even shorter, less than 2 s. Therefore, biological systems have developed several mechanisms
to protect CP from decomposition.
The decomposition of CP has been proposed as a 2-step unimolecular elimination of cyanate via
an intramolecular proton transfer to yield the phosphate anion at near neutral pH (Figure 7) [125].
The formation of a 6-membered ring structure by a hydrogen bond between the amino nitrogen
and the phosphate oxygen is believed to be a critical force in driving the proton transfer. In this
conformation, the P-O-C-N dihedral angle is close to 0◦ . It is interesting to observe that all CP bound
in the enzymes have a conformation with the P-O-C-N dihedral angle close to 180◦ [22,99,126–129].
In this conformation, the CP is quite stable. It has been observed previously that human OTCase
can protect the CP from decomposition for weeks in the active site [128]. Recent careful studies
demonstrated that the binding of CP to the active sites of enzymes such as aspartate and ornithine
transcarbamylases reduces the rate of thermal decomposition of CP by a factor of >5000 by restricting
the CP conformation to a disfavorable geometry for decomposition [124]. In addition to the enzymatic
protection of CP using the above mechanism when the second substrates are not available, most of
these CP bound enzymes have high affinity for CP with a Km in the sub-micromole range, and a fast
turnover rate for the conversion of CP to products. Furthermore, the partial channeling of CP from
CPS to downstream enzymes has been suggested as part of the pyrimidine pathway in yeast [130,131],
Neurospora [132,133], and mammals [134,135] and in the mammalian urea cycle [136,137].
Since CP is highly labile at elevated temperatures, the metabolic channeling between CPS and
downstream enzymes is essential for thermophilic organisms. Kinetic experiments provide evidence
for CP channeling in thermos ZO5 [138], P. abyssi [8], and A. aeolicus [139]. Co-immunoprecipitation and
cross-linking experiments confirmed that the CP generating enzyme, anabolic CK, forms a functional
complex with OTCase physically in P. furiosus for efficient CP channeling [51].

the CP conformation to a disfavorable geometry for decomposition [124]. In addition to the enzymatic
protection of CP using the above mechanism when the second substrates are not available, most of
these CP bound enzymes have high affinity for CP with a Km in the sub-micromole range, and a fast
turnover rate for the conversion of CP to products. Furthermore, the partial channeling of CP from
CPS to
downstream
enzymes has been suggested as part of the pyrimidine pathway in 13yeast
Biology
2018,
7, 34
of 23
[130,131], Neurospora [132,133], and mammals [134,135] and in the mammalian urea cycle [136,137].
H
H

O

OH

H
N

O-

C

P
O

O-

P
OO

-O

O

N

N

C

C

O

O-

cynate
Figure 7. Schematic
Schematic drawing
drawing for
for the proposed thermal decomposition
decomposition of CP via an intramolecular
◦.
proton transfer.
transfer. In this conformation,
conformation, the
the P-O-C-N
P-O-C-N dihedral
dihedral angle
angle is
is close
close to
to 00°.

7. CP Accumulation and Health
In lower organisms there is generally one CPS enzyme to produce CP for both pyrimidine and
arginine biosynthetic pathways, while in higher organisms there are two separate enzymes specific for
each pathway. In humans, the formation of CP specific for pyrimidine synthesis occurs in the cytosol
of all tissues and is catalyzed by CPS II, a part of the CAD complex, whereas CP destined for the urea
cycle is formed in liver mitochondria and catalyzed by CPS I (Figure 8) [140]. The flux through the
urea cycle is normally much larger than flux through the pyrimidine biosynthesis pathway so that the
diversion of just a fraction of mitochondrially generated CP will substantially increase the flux through
the pyrimidine biosynthesis pathway [141]. CP can accumulate within the mitochondrial matrix when
the flux of CP formation by CPS I is larger than the CP consumption by OTCase. In normal conditions,
CP generated from CPS I will react with ornithine to form citrulline immediately due to the much
higher enzymatic activity of OTCase compared to CPS I. However, in some conditions such as OTCase
deficiency or decreased supply of ornithine due to ornithine transporter (ORNT 1) deficiency, or lack
of ornithine, citrulline, and arginine in the diets, CP will accumulate in the matrix. Furthermore,
these conditions will also cause elevation of ammonia, which will provide more substrate to CPS I,
increasing CP production for more CP accumulation.
There are two fates for accumulated CP in the matrix: decomposition or spillover into
the cytoplasm, where it enters into CAD beyond the control step for pyrimidine nucleotide
biosynthesis [142]. The decomposition of CP will result in the production of cyanate, a strong
carbamylation agent (Figure 7). Carbamylation induced by urea-derived cyanate was one of the first
post-translational modification of proteins to be described and identified in denaturation–renaturation
studies of proteins with urea [143]. Carbamylation of proteins can yield both functional and structural
changes in the target proteins that link to many disease conditions such as chronic kidney disease [144]
and atherosclerotic vascular disease [145]. However, no disease condition has been reported related to
the CP-derived cyanate production, which may be due to the lack of large amounts of cyanate
accumulation in the matrix, or a protection mechanism of CP in the matrix that prevents CP
decomposition to cyanate, or unrecognized disease conditions related to the CP-derived cyanate.
In comparison to the first fate of accumulated CP in the matrix, the second fate of CP is
better understood. When CP enters into CAD, it will combine with aspartate to produce carbamyl
aspartate by the action of ATCase, and then is further converted to orotic acid causing its elevation,
eventfully resulting in nucleotide imbalance [145], a possible mechanism contributing to the
cancer-promoting action of orotic acid [146]. Germline OTCase deficiency results in CP accumulation
that feeds the pyrimidine pathway, causing orotic acid elevation and pyrimidine accumulation.
Liver cell carcinoma has been described in an older heterozygous female OTCase deficiency patient,
suggesting the possible link between CP accumulation and liver cancer [147].
Recently, it was found that CPS1 expression correlates inversely with liver kinase B1 (LKB1)
activation in non-small-cell lung cancer (NSCLC) [148,149]. Surprisingly, CPS1 expression was found
predominantly in the cytoplasm in these lung cancer cells, in contrast to the CPS1 only expressed
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inside the mitochondria in the liver and intestinal epithelial cells. It seems that cancer cells hijack CPS1
to provide an alternative pool of CP due to the increased need for pyrimidine and for maintenance of
purine/pyrimidine balance. Silencing CPS I in these cancer cells will induce cell death and reduce
Biology
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substrates. For example, the gene Asm21 in the biosynthetic gene cluster of ansamitocin, which
encodes an O-transcarbamylase, catalyzes not only the carbamylation of the C-7 hydroxyl group on
the ansamitocin backbone with various variations, but also the carbamylation of the C-4 hydroxyl
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to the N-transcarbamylases, the structure and function of O-transcarbamylases are less studied,
particularly how these enzymes recognize such diverse substrates. For example, the gene Asm21 in the
biosynthetic gene cluster of ansamitocin, which encodes an O-transcarbamylase, catalyzes not only the
carbamylation of the C-7 hydroxyl group on the ansamitocin backbone with various variations, but also
the carbamylation of the C-4 hydroxyl group of the N-β-D-glucosyl moiety of ansamitocinoside [21].
In order to understand its recognition mechanism, the elucidation of structures complexed with its
various substrates is essential.
CP is produced using three very different enzymes. Among them, the ATP-grasp fold based
enzyme is the most popular one for all forms of life to make CP for essential arginine/urea and
pyrimidine biosynthetic pathways. The catalytic mechanisms using the three steps of partial reaction
for generating CP are now well understood. The molecular mechanism for NAG activation of human
CPS I has been elucidated via the structural determination of human CPS I in the absence and presence
of NAG [6]. However, the allosteric molecular mechanism for UMP induced inhibition of CPS II still
remains obscure because structures of E. coli CPS II that were determined are all in the active form
similar to that of CPS I in the presence of NAG. Whether the conformation of the inactive form of CPS
II exists and is similar to that of CPS I remains to be established.
Currently, the three catabolic transcarbamylases, ornithine, putrescine, and ureidoglycine
transcarbamylase, which use ureido-containing compounds, citrulline, agmatine, and allantoate,
as energy sources to generate CP have been firmly established. It cannot be ruled out that there are
other catabolic transcarbamylases that use other different ureido-containing chemicals as substrates.
The molecular identity of oxamate transcarbamylase using oxalurate as an energy source remains to
be elucidated even though earlier experiments indicated that such catabolic transcarbamylase exists.
Finally, the true substrate for ygeW encoded catabolic transcarbamylase needs to be established.
As an essential metabolite in the urea cycle, lack of or decreased CP production due to CPS I
deficiency [150], lack of the activator NAG due to N-acetyl-glutamate synthase (NAGS) deficiency [151],
or decreased supply of carbon dioxide due to carbonic anhydrase VA deficiency [152] will disrupt
the urea cycle resulting in hyperammonemia. However, many disease conditions will cause the
accumulation of CP. Effects of accumulation of the energy-rich and labile CP on human health is
poorly understood. Furthermore, more detailed studies are certainly warranted to understand the
relationship between CP and cancers as many studies demonstrate that cancer cells might hijack CPS I,
probably NAGS as well, in order to meet the increased need for CP in cancer cells.
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